ATE242268T1 - Inhibierung vom abnormalen zellwachstum mit analogen des corticotropin-freisetzenden hormons - Google Patents

Inhibierung vom abnormalen zellwachstum mit analogen des corticotropin-freisetzenden hormons

Info

Publication number
ATE242268T1
ATE242268T1 AT00965143T AT00965143T ATE242268T1 AT E242268 T1 ATE242268 T1 AT E242268T1 AT 00965143 T AT00965143 T AT 00965143T AT 00965143 T AT00965143 T AT 00965143T AT E242268 T1 ATE242268 T1 AT E242268T1
Authority
AT
Austria
Prior art keywords
corticotropin
abnormal cell
inhibition
analogs
cell growth
Prior art date
Application number
AT00965143T
Other languages
English (en)
Inventor
Edward T Wei
Andrzej T Slominski
Original Assignee
Univ California
Univ Loyola Chicago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Univ Loyola Chicago filed Critical Univ California
Application granted granted Critical
Publication of ATE242268T1 publication Critical patent/ATE242268T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT00965143T 1999-09-21 2000-09-19 Inhibierung vom abnormalen zellwachstum mit analogen des corticotropin-freisetzenden hormons ATE242268T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/400,716 US6319900B1 (en) 1999-09-21 1999-09-21 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
PCT/US2000/025652 WO2001021191A2 (en) 1999-09-21 2000-09-19 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs

Publications (1)

Publication Number Publication Date
ATE242268T1 true ATE242268T1 (de) 2003-06-15

Family

ID=23584714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965143T ATE242268T1 (de) 1999-09-21 2000-09-19 Inhibierung vom abnormalen zellwachstum mit analogen des corticotropin-freisetzenden hormons

Country Status (8)

Country Link
US (2) US6319900B1 (de)
EP (1) EP1214347B1 (de)
JP (1) JP2003509466A (de)
AT (1) ATE242268T1 (de)
AU (1) AU775508B2 (de)
CA (1) CA2384816A1 (de)
DE (1) DE60003198D1 (de)
WO (1) WO2001021191A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19837387A1 (de) * 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
US6849600B2 (en) * 2002-03-25 2005-02-01 The Regents Of The University Of California, Berkeley Corticotropin-releasing hormone analogs
RU2010114051A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение grf-1(1-29) и кортиколиберина в качестве терапевтических средств
EP2190465A2 (de) * 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Verwendung eines peptids als therapeutisches mittel
WO2009043526A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
NZ588877A (en) * 2008-04-30 2012-08-31 Neutron Row Methods of using corticotropin-releasing factor for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480869A (en) 1990-01-09 1996-01-02 The Regents Of The University Of California Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
US5777073A (en) * 1994-12-12 1998-07-07 The Salk Institute For Biological Studies Cyclic CRF antagonist peptides
US5663292A (en) 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs

Also Published As

Publication number Publication date
EP1214347B1 (de) 2003-06-04
AU7591000A (en) 2001-04-24
US6319900B1 (en) 2001-11-20
EP1214347A2 (de) 2002-06-19
US20020142962A1 (en) 2002-10-03
JP2003509466A (ja) 2003-03-11
WO2001021191A3 (en) 2002-01-10
CA2384816A1 (en) 2001-03-29
WO2001021191A2 (en) 2001-03-29
US6803359B2 (en) 2004-10-12
DE60003198D1 (de) 2003-07-10
AU775508B2 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
ES2140082T3 (es) Composiciones peptidicas con actividad de tipo factor de crecimiento.
DE69634640D1 (de) Mutierte alpha-amylase enzyme mit erhöhter stabilität
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
PT720482E (pt) Prosaposina e peptidos derivados da citocina utilizados como agentes
NO20013071D0 (no) Fremgangsmåter og sammensetninger for behandling av celleproliferative forstyrrelser
MX2009001452A (es) Peptidos que tienen actividad farmacologica para tratar trastornos asociados con migracion celular alterada, tal como cancer.
DE69635675D1 (de) Verkürzter aus einer gliazelllinie gewonnener neurotropher faktor
ATE242268T1 (de) Inhibierung vom abnormalen zellwachstum mit analogen des corticotropin-freisetzenden hormons
DE69736487D1 (de) Peptidzusammensetzung mit wachstumsfaktor-ähnlicher aktivität
DE60318026D1 (de) Hybrid-hepatozyten-wachstumsfaktorgen mit hoher expressionseffizienz von zwei hepatozyten-wachstumsfaktor-heterotypen
DE69403459D1 (de) Peptidboronsäurederivate mit protease inhibierenden aktivität
EP0662516A4 (de) Neuartiges elafinderivat.
MX2023002047A (es) Proteinas de interleucina 2 (il-2) glucosiladas y usos de las mismas.
ES2132609T3 (es) Derivados del acido arilacetico y su empleo como fungicidas.
ATE237634T1 (de) Analogen des keratinozytenwachstumfaktors
TR200103004T2 (tr) Pirolidinkarbonilamino siklik disülfitler.
ATE259244T1 (de) Vermeidung von gastrointestinaler schädigung
CY1113771T1 (el) Αναλογα 1-αποαμινο-8-d-αργινυλ αγγειοπιεσινης
DE69939586D1 (de) Inhibitoren für die gefässneubildung
DK1289513T3 (da) Anvendelse af aloe-emodin i behandlingen af neuroektodermale tumorer
EP0438600A4 (en) Enzymes which participate in c-terminal amidation, and production and use thereof
TW200505945A (en) Oligopeptides
RS52910B (en) POLYMER CONJUGATES OF MUTATED NEUBLASTINE
Baxter et al. The high-molecular-weight ribonucleic acid species of soya-bean mitochondria.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties